San Diego Business Journal

A Side Effect of Brexit May Be Damage to Pharma Research

PHARMA: UK’s Exit From EU Brings Huge Regulatory Questions By Brittany Meiling Originally published August 3, 2017 at 2:13 p.m., updated August 3, 2017 at 2:13 p.m.

Learn More About Brexit

To learn more about the impact of Brexit on European clinical studies, locals can attend a free informational session hosted by Sherpa Clinical Packaging at its headquarters at 6166 Nancy Ridge Drive, San Diego.

Topics will include the QP process and the impact of Brexit on European Depot Services.

The event, called the 2017 Sherpa Summer Seminar, takes place on Aug. 10 from 2-6 p.m.

— San Diego drugmakers are facing fallout from divisive politics across the pond, as local biotechs work to understand how Brexit will affect their research (and their bottom line)...


Page 1 of 3.

Take 1 minute to subscribe and you’ll get this story immediately, plus:

Already a subscriber? Sign in

  • 51 weekly issues: $153 value
  • Subscriber-only digital content every business day, plus full access to archives: $150 value
  • Book of Lists — the biggest, hottest companies in San Diego: $75 value
  • NEW: San Diego 500 — influential business leaders you need to know: $50 value
  • Total Package Value: $428

Yours for only $129